Predictive sFlt-1/PlGF ratio indicates risks of severe preeclampsia and related outcomes in hypertensive pregnant women.
The sFlt-1/PlGF ratio >38 measured on the Elecsys platform predicted the development of sPE, delivery, and adverse maternal and fetal/neonatal outcomes within two weeks of testing among preterm pregnant women hospitalized with HDP. (Funded by Cedars-Sinai Medical Center and Roche Diagnostics).
No takes yet. Share an insight, caveat, or question.
Berg et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: